Australia to Introduce New Tobacco Packaging Rules with Health Warnings on Every Cigarette

Nov.15.2024
Australia to Introduce New Tobacco Packaging Rules with Health Warnings on Every Cigarette
Australia is set to implement tobacco packaging regulations, with health warnings on every cigarette, aiming to improve public health and discourage smoking.

According to a report by 7 News on November 14th, Australia is on the verge of implementing major tobacco packaging reforms. This comes over a decade after the country first adopted plain packaging, a global first.

 

According to the new regulations, health warning labels must be printed on each cigarette. This measure is modeled after Canada's approach. Canada began implementing similar laws last year, with local officials hoping further to alert smokers to the dangers of tobacco products. The Australian Department of Health and Ageing released a proposed new regulation on October 30th, with feedback collection ending on November 8th.

 

The new regulations aim to "improve public health by discouraging smoking and the use of regulated tobacco items", as well as encouraging existing users to give up their habit.

 

The proposed labels are:

 

  • Toxic addiction
  • Poisons in every puff
  • Causes 16 cancers
  • Damages your lungs
  • Damages DNA
  • Who is this harming?
  • What is this costing you?
  • Shortens your life

 

According to a report from the Australian Institute of Health and Welfare, the smoking rate continues to decline, with the proportion of Australians who have never smoked reaching 65%. In recent years, there has been a significant increase in the use of vapes, rising from 11.3% in 2019 to 19.8% in 2022-2023. Currently, about half of e-cigarette users use them daily, which represents a 42% increase from 2019.

 

In 2012, the plain packaging requirement for tobacco products was implemented, which calls for standardized colors and health warnings on packaging. More than 20 countries have followed Australia's lead in implementing plain packaging for vapes.

 

Health Minister Mark Butler called for further action on using vapes earlier this year. He said: "We have a once-in-a-generation opportunity and responsibility to act now, to safeguard the health of young Australians for generations to come."

 

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives